Bakken J S, Sanders C C, Thomson K S
J Infect Dis. 1987 Jun;155(6):1220-5. doi: 10.1093/infdis/155.6.1220.
A strain of Escherichia coli (MG/32) was recovered from the blood of a patient who had received ceftazidime for eight weeks. The isolate was resistant to ceftazidime but susceptible to other third-generation cephalosporins. Alterations in outer membrane proteins were implicated in this selective ceftazidime resistance. As ceftazidime susceptibility was regained, the quantity of outer membrane proteins of 37,000 and 39,000 molecular weight increased. Although the isolate possessed a TEM-1 beta-lactamase, this enzyme was not involved in the selective resistance to ceftazidime; it did not disappear on reacquisition of ceftazidime susceptibility and did not hydrolyze the drug. Potassium clavulanate enhanced the activity of ceftazidime against E. coli strain MG/32, but this enhancement was due to a direct effect on outer membrane proteins and not to beta-lactamase inhibition.
从一名接受了八周头孢他啶治疗的患者血液中分离出一株大肠杆菌(MG/32)。该分离株对头孢他啶耐药,但对其他第三代头孢菌素敏感。外膜蛋白的改变与这种对头孢他啶的选择性耐药有关。当恢复对头孢他啶的敏感性时,分子量为37000和39000的外膜蛋白数量增加。尽管该分离株具有TEM-1β-内酰胺酶,但这种酶与对头孢他啶的选择性耐药无关;在重新获得对头孢他啶的敏感性时它并未消失,也不水解该药物。克拉维酸钾增强了头孢他啶对大肠杆菌MG/32菌株的活性,但这种增强是由于对外膜蛋白的直接作用,而非β-内酰胺酶抑制作用。